Citigroup
IMA

Citigroup’s ImageneBio Inc IMA Stock Holding History

Citigroup’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-224
Closed -$1.12K – 5978
2026
Q1 		$1.12K Buy
+224
New +$1.45K ﹤0.01% 5472
2024
Q3 		– Sell
-417
Closed -$8.26K – 5731
2024
Q2 		$8.26K Sell
417
-67
-14% -$1.18K ﹤0.01% 5188
2024
Q1 		$8.24K Buy
484
+98
+25% +$1.78K ﹤0.01% 5243
2023
Q4 		$9.12K Buy
386
+385
+38,500% +$12.6K ﹤0.01% 5213
2023
Q3 		$43 Sell
1
-527
-100% -$31.7K ﹤0.01% 5537
2023
Q2 		$41.5K Buy
528
+169
+47% +$12.1K ﹤0.01% 4736
2023
Q1 		$14.8K Buy
359
+301
+519% +$13.8K ﹤0.01% 4603
2022
Q4 		$1.86K Buy
58
+1
+2% +$32 ﹤0.01% 5258
2022
Q3 		$2K Sell
57
-21
-27% -$1.21K ﹤0.01% 5502
2022
Q2 		$4K Sell
78
-209
-73% -$11.5K ﹤0.01% 5686
2022
Q1 		$21K Sell
287
-468
-62% -$49.8K ﹤0.01% 5114
2021
Q4 		$114K Buy
755
+641
+562% +$104K ﹤0.01% 4662
2021
Q3 		$17K Buy
114
+78
+217% +$11.3K ﹤0.01% 5289
2021
Q2 		$6K Buy
+36
New +$7.94K ﹤0.01% 5806

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Citigroup's IMA Position: Q2 2026 in Review

Citigroup sold out of ImageneBio Inc (IMA) in Q2 2026, closing a stake of 224 shares — an estimated $1.12K sold.

Citigroup first reported a position in IMA in Q2 2021 and held it in 14 quarters. The position peaked at $114K in Q4 2021. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Citigroup reported no remaining ImageneBio Inc position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 224 ImageneBio Inc shares in Q2 2026, an estimated $1.12K.
  • Citigroup first reported a position in ImageneBio Inc in Q2 2021 and held it in 14 quarters.
  • Citigroup's ImageneBio Inc position peaked at $114K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.